Galectin-9 in Cancer Therapy
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
130-137
Author(s):
Shintaro Fujihara, Hirohito Mori, Hideki Kobara, Kazi Rafiq, Toshiro Niki, Mitsuomi Hirashima and Tsutomu Masaki
The Wnt Pathway: Emerging Anticancer Strategies
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
138-147
Author(s):
Aman Gupta, Anukriti Verma, Ashutosh K. Mishra, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain
In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2963-2969
Author(s):
Hong M. Moulton
Intracellular Fate of Peptide-Mediated Delivered Cargoes
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2924-2942
Author(s):
Irene Martin, Meritxell Teixido and Ernest Giralt
Chitosan Nanoparticles for Melanoma Cancer Treatment by Photodynamic Therapy and Electrochemotherapy Using Aminolevulinic Acid Derivatives
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1904-1911
Author(s):
D. M. Ferreira, Y. Y. Saga, E. Aluicio- Sarduy and A.C. Tedesco
The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression
Journal:
Current Drug Targets
Volume:
14
Page:
460-471
Author(s):
Jeffry L. Dean and Karen E. Knudsen
Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential
Journal:
Current Drug Targets
Volume:
14
Page:
450-459
Author(s):
Nicole M. White, Felix Y. Feng and Christopher A. Maher
Synthetic Survey and Activity of 2'-deoxy-methanocarba Nucleosides
Journal:
Current Organic Synthesis
Volume:
10
Page:
210-240
Author(s):
Krassimira P. Guerra and Carlos A. M. Afonso
The p53-p66Shc Apoptotic Pathway is Dispensable for Tumor Suppression whereas the p66Shc-generated Oxidative Stress Initiates Tumorigenesis
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2708-2714
Author(s):
Elena Beltrami, Silvia Valtorta, Rosamaria Moresco, Raluca Marcu, Sara Belloli, Ambrogio Fassina, Ferruccio Fazio, Piergiuseppe Pelicci and Marco Giorgio
Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies
Journal:
Current Topics in Medicinal Chemistry
Volume:
12
Page:
2745-2762
Author(s):
Alejandro Speck-Planche, Feng Luan and M.N.D.S. Cordeiro